Pivotal Stroke Trials Presented at this Year'...

Dr. Gillian L. Gordon Perue discusses asundexian and the OCEANIC-STROKE trial. Show citation: Sharma M, Dong Q, Hirano T, et al. Asundexian for Secondary Stroke Prevention. N Engl J Med. 2026;394(15):1467-1479. doi:10.1056/NEJMoa2513880 

Dr. Madeline Russell discusses a common complication faced by patients with acute ischemic stroke. Show citation: Schwarz G, Cascio Rizzo A, Ambler G, et al. Contrast-Associated Acute Kidney Injury After Thrombectomy for Ischemic Stroke: Prognostic Impact and CAN-REST Predictive ...  Show more

We’re coming to you live from the Arthroscopy Association of North America's Annual Meeting in Boston, MA!  This year, orthopedic professionals gathered from all over the world at the AANA meeting to take part in an exciting educational line up. The educational program wa ...

Send us Fan MailThe path to FDA approved prescribable medicine has been a long and precarious one for psychedelics. However, recent reports by some of the major players in the psychedelic medicine space show promising results from clinical trials involving psilocybin and 5-MeO-DM ...  Show more

Dr. Jessica Ailani talks with Dr. Ian Carroll about intracranial hypotension, the challenges of diagnosing and treating patients with CSF leaks, and the study's findings. Read the related article in Neurology.  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for mor ...  Show more

In this podcast, Hartmut Döhner, Hematologist-Oncologist and Professor of Medicine in Germany, discusses with Dr. Nathalie van Havre the role of genomic characterization in the classification, prognosis and treatment of myeloid neoplasms. Discover the main methods of genomic test ...  Show more